Search research articles
Contact Us
Filters
Showing results (61-70 of 96) with videos related to
Page
of 10
Sort By:
Pneumologie (Stuttgart, Germany)
|
March 10, 2001
[Long-term treatment of primary pulmonary hypertension with inhaled iloprost]
M M Hoeper, M Schwarze, S Ehlerding, et al.
The New England Journal of Medicine
|
June 22, 2000
Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue
M M Hoeper, M Schwarze, S Ehlerding, et al.
The European Respiratory Journal
|
March 2, 2005
Bosentan therapy for portopulmonary hypertension
M M Hoeper, M Halank, C Marx, et al.
Zeitschrift Fur Gastroenterologie
|
September 3, 2011
Ambrisentan improves exercise capacity and symptoms in patients with portopulmonary hypertension
M Halank, L Knudsen, H-J Seyfarth, et al.
The European Respiratory Journal
|
April 20, 2001
Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension
T Gessler, T Schmehl, M M Hoeper, et al.
The European Respiratory Journal
|
July 27, 2007
Experience with inhaled iloprost and bosentan in portopulmonary hypertension
M M Hoeper, H J Seyfarth, G Hoeffken, et al.
The European Respiratory Journal
|
June 10, 2010
Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study
H A Ghofrani, M M Hoeper, M Halank, et al.
Journal of the American College of Cardiology
|
January 15, 2000
A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group
M M Hoeper, H Olschewski, H A Ghofrani, et al.
The European Respiratory Journal
|
July 22, 1999
Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs
J M Hohlfeld, M Strüber, K Ahlf, et al.
Thorax
|
May 31, 2002
Peripheral airway obstruction in primary pulmonary hypertension
F J Meyer, R Ewert, M M Hoeper, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 96) with videos related to
Sort By:
Page
of 10
Pneumologie (Stuttgart, Germany)
|
March 10, 2001
[Long-term treatment of primary pulmonary hypertension with inhaled iloprost]
M M Hoeper, M Schwarze, S Ehlerding, et al.
The New England Journal of Medicine
|
June 22, 2000
Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue
M M Hoeper, M Schwarze, S Ehlerding, et al.
The European Respiratory Journal
|
March 2, 2005
Bosentan therapy for portopulmonary hypertension
M M Hoeper, M Halank, C Marx, et al.
Zeitschrift Fur Gastroenterologie
|
September 3, 2011
Ambrisentan improves exercise capacity and symptoms in patients with portopulmonary hypertension
M Halank, L Knudsen, H-J Seyfarth, et al.
The European Respiratory Journal
|
April 20, 2001
Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension
T Gessler, T Schmehl, M M Hoeper, et al.
The European Respiratory Journal
|
July 27, 2007
Experience with inhaled iloprost and bosentan in portopulmonary hypertension
M M Hoeper, H J Seyfarth, G Hoeffken, et al.
The European Respiratory Journal
|
June 10, 2010
Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study
H A Ghofrani, M M Hoeper, M Halank, et al.
Journal of the American College of Cardiology
|
January 15, 2000
A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group
M M Hoeper, H Olschewski, H A Ghofrani, et al.
The European Respiratory Journal
|
July 22, 1999
Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs
J M Hohlfeld, M Strüber, K Ahlf, et al.
Thorax
|
May 31, 2002
Peripheral airway obstruction in primary pulmonary hypertension
F J Meyer, R Ewert, M M Hoeper, et al.
Page
of 10